Translational Liver Research group


​The Translational Liver Research (TLR) group focus on liver disease-related research with major interest on three core themes:
  • ​Understanding the underlying disease mechanisms and cellular crosstalk in liver diseases;
  • Development of Targeted nanotherapeutics/nanotheranostics for diagnosis and treatment of liver diseases; and
  • Development of human disease mimic platforms for disease modelling and drug discovery.
The combination of fundamental studies with drug discovery and application-oriented research summarizes the crossover of different biomedical disciplines present in our group. The three research themes are interdependent and cover the complete knowledge chain from understanding diseases to designing theranostics and validating in different developed platforms (from in vitro cell culture, in vivo preclinical models to human disease-mimic models). By use of in vitro and in vivo techniques in cooperation with partners in academia and industry we aim for translational medicine in order to improve clinical applications and the quality of life of patients.

News

  • Alexander won the Best poster prize at FIGON DMD 2019.
  • Translational Liver Research now a part of the Department of Medical Cell BioPhysics from 1st January 2020.
  • Hilde won the 3rd best presentation prize at the Dutch Liver Retreat 2020.
  • Richell selected for the young investigator bursary (650€), The International Liver Congress, EASL, London, April 2020.
  • Keynote lecture by Ruchi at the Matrix Biology Annual Meeting, May 2020.
  • Amit Khurana awarded with DAAD-PRIME postdoctoral fellowship and will join TLR in September 2020.
  • Eline awarded EASL PhD student fellowship Juan Rodes 2020.

Events

  • Dutch Liver Retreat, NASL, The Netherlands, February 2020
  • The International Liver Congress, EASL, Digital, August 2020
  • FIGON DMD, The Netherlands, October 2020
  • AASLD The Liver Meeting, Boston, November 2020